Related Experiment Videos
New concepts in dysmenorrhea.
American Journal of Obstetrics and Gynecology
|April 1, 1978
Summary
Primary dysmenorrhea, a common cause of pain and lost work hours, may be caused by increased prostaglandins. Antiprostaglandin agents show promise for treating this condition.
Area of Science:
- Gynecology
- Pharmacology
Background:
- Primary dysmenorrhea is a prevalent gynecologic complaint.
- Its exact cause remains unclear, impacting work productivity.
- Emerging research links it to elevated endometrial prostaglandin levels.
Purpose of the Study:
- To investigate the role of prostaglandins in primary dysmenorrhea.
- To evaluate the efficacy of antiprostaglandin agents in managing dysmenorrhea.
Main Methods:
- Review of recent studies and clinical trials.
- Analysis of prostaglandin's role in myometrial contractility and uterine ischemia.
- Examination of antiprostaglandin agents like indomethacin and fenamates.
Main Results:
- Prostaglandins induce excessive myometrial contractility, potentially causing uterine ischemia and pain.
- Antiprostaglandin agents inhibit prostaglandin synthesis and action.
- Conventional therapies may reduce prostaglandin levels, explaining their effectiveness.
Conclusions:
- Increased prostaglandin production is a likely cause of primary dysmenorrhea.
- Antiprostaglandin compounds warrant further investigation for effective dysmenorrhea treatment.
- Developing optimized formulations of these agents is crucial for managing this disorder.